Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R05CB01	FLUIMUCIL MUCOLYTIC	B	N-acetylcysteine - 2%	2%	Syrup	595,322 L.L
R05CB01	EXOMUC	B	N-acetylcysteine - 200mg	200mg	Granules for solution	588,603 L.L
R05CB01	FLUIMUCIL	B	N-acetylcysteine - 600mg	600mg	Tablet, effervescent	567,102 L.L
R05CB01	ACC LONG	G	N-acetylcysteine - 600mg, Vitamin C - 75mg	600mg	Tablet, effervescent	286,238 L.L
D10AF05	NADIXA	G	Nadifloxacin - 1%	1%	Cream	850,652 L.L
D10AF05	NAXIDERM	G	Nadifloxacin - 1%	1%	Gel	826,783 L.L
C04AX21	NAFTIPRAX	B	Naftidrofuryl hydrogen oxalate - 200mg	200mg	Tablet, film coated	614,328 L.L
C04AX21	NAFTILUX	B	Naftidrofuryl oxalate acid - 200mg	200mg	Capsule	432,717 L.L
D01AE22	EXODERIL	B	Naftifine HCl - 10mg/g	1%	Cream	345,368 L.L
D01AE22	EXODERIL	B	Naftifine HCl - 10ml/ml	1%	Solution	159,917 L.L
N02AF02	NALBUPHINE RENAUDIN 1%	G	Nalbuphine HCl - 20mg/2ml	20mg/2ml	Injectable solution	1,181,238 L.L
A08AA62	CONTRAVE	B	Naltrexone Hydrochloride - 8mg, Bupropion Hydrochloride - 90mg		Tablet, prolonged release	11,653,550 L.L
S01GA51	NAPHCON A	B	Naphazoline HCl - 0.025%, Pheniramine maleate - 0.3%		Drops solution	369,557 L.L
S01GA01	IRIDINA DUE	G	Naphazoline HCl - 0.5mg/ml	0.5mg/ml	Drops solution	469,001 L.L
M01AE02	NOPAIN DS	G	Naproxen (sodium) - 500mg	500mg	Tablet, film coated	235,172 L.L
M01AE02	NAPROXENE SODIQUE ARROW	G	Naproxen (sodium) - 550mg	550mg	Tablet, film coated, scored	255,330 L.L
M01AE02	PROXEN 250	B	Naproxen - 250mg	250mg	Tablet, film coated	542,912 L.L
M01AE02	PROXEN 500	B	Naproxen - 500mg	500mg	Tablet, film coated	841,245 L.L
M01AE02	ANODYNE 500	G	Naproxen - 500mg	500mg	Suppository	342,680 L.L
L04AA23	TYSABRI	BioTech	Natalizumab - 300mg/15ml	300mg/15ml	Injectable concentrated solution	126,830,594 L.L
C07AB12	NEBILET	B	Nebivolol HCl - 5mg	5mg	Tablet, scored	694,767 L.L
C07AB12	BLOVEK	G	Nebivolol HCl - 5mg		Tablet	511,940 L.L
C07AB12	NEBIVOLOL BIOGARAN	G	Nebivolol HCl - 5mg	5mg	Tablet, scored	529,474 L.L
C07AB12	NEVILOC	G	Nebivolol HCl - 5mg	5mg	Tablet	476,104 L.L
C07BB12	NEBILET PLUS	B	Nebivolol HCl - 5mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	716,268 L.L
C07BB12	NEBILET PLUS	B	Nebivolol HCl - 5mg, Hydrochlorothiazide - 25mg		Tablet, film coated	716,268 L.L
N02BG06	ACUPAN	B	Nefopam HCl - 20mg	20mg	Injectable solution	365,525 L.L
N02BG06	NEO-PAN	G	Nefopam HCl - 20mg/ml	20mg/ml	Injectable solution	494,534 L.L
D07CC01	BETASONE-N	G	Neomycin (sulfate) - 3.5mg/g, Betamethasone (valerate) - 1mg/g		Cream	398,033 L.L
D06AX	BATRAMYCIN	B	Neomycin (sulfate) - 5000IU/g, Bacitracin - 250IU/g		Ointment	513,348 L.L